Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Structure-based optimization of a PDZ binding motif within a viral peptide stimulates neurite outgrowth.

Khan Z, Terrien E, Delhommel F, Lefebvre-Omar C, Bohl D, Vitry S, Bernard C, Ramirez J, Chaffotte A, Ricquier K, Vincentelli R, Buc H, Prehaud C, Wolff N, Lafon M.

J Biol Chem. 2019 Jul 25. pii: jbc.RA119.008238. doi: 10.1074/jbc.RA119.008238. [Epub ahead of print]

2.

Sarcoidosis-like reaction in metastatic triple negative breast cancer treated by anti-PD-L1.

Lafon M, Blaye C, Kind M, Bechade D, Chassaigne F, Italiano A, Grellety T.

Breast J. 2019 Jun 4. doi: 10.1111/tbj.13386. [Epub ahead of print]

PMID:
31165561
3.

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain.

da Costa A, Prehaud C, Bakoa F, Afonso P, Ceccaldi PE, Lafaye P, Lafon M.

J Vis Exp. 2019 Apr 9;(146). doi: 10.3791/59220.

PMID:
31033945
4.

Clinical and biological features of enteroviral meningitis among adults and children and factors associated with severity and length of stay.

Vareil M, Wille H, Kassab S, Le-Cornec C, Puges M, Desclaux A, Lafon ME, Tumiotto C, Cazanave C, Neau D.

J Clin Virol. 2018 Jul;104:56-60. doi: 10.1016/j.jcv.2018.04.017. Epub 2018 May 1.

PMID:
29738895
5.

Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study.

da Costa A, Prehaud C, Khou C, Pardigon N, Saulnier A, Nougarede N, Lafon M.

Biologicals. 2018 May;53:19-29. doi: 10.1016/j.biologicals.2018.03.004. Epub 2018 Mar 24.

6.

In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity.

Phoolcharoen W, Banyard AC, Prehaud C, Selden D, Wu G, Birch CPD, Szeto TH, Lafon M, Fooks AR, Ma JK.

Vaccine. 2019 Aug 2;37(33):4673-4680. doi: 10.1016/j.vaccine.2018.02.057. Epub 2018 Mar 6.

7.

Rapid Adenovirus typing method for species identification.

Rayne F, Wittkop L, Bader C, Kassab S, Tumiotto C, Berciaud S, Wodrich H, Lafon ME; Typadeno Study Members.

J Virol Methods. 2017 Nov;249:156-160. doi: 10.1016/j.jviromet.2017.09.009. Epub 2017 Sep 14.

PMID:
28918074
8.

Comparison of G protein sequences of South African street rabies viruses showing distinct progression of the disease in a mouse model of experimental rabies.

Seo W, Servat A, Cliquet F, Akinbowale J, Prehaud C, Lafon M, Sabeta C.

Microbes Infect. 2017 Sep - Oct;19(9-10):485-491. doi: 10.1016/j.micinf.2017.05.005. Epub 2017 Jun 13.

PMID:
28627433
9.

Investigation of rabies virus glycoprotein carboxyl terminus as an in vitro predictive tool of neurovirulence. A 3R approach.

Seo W, Prehaud C, Khan Z, Sabeta C, Lafon M.

Microbes Infect. 2017 Sep - Oct;19(9-10):476-484. doi: 10.1016/j.micinf.2017.05.006. Epub 2017 Jun 8.

10.

Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device.

Phoolcharoen W, Prehaud C, van Dolleweerd CJ, Both L, da Costa A, Lafon M, Ma JK.

Plant Biotechnol J. 2017 Oct;15(10):1331-1339. doi: 10.1111/pbi.12719. Epub 2017 Apr 19.

11.

Red palms associated with adenovirus gastroenteritis.

Chong JH, Mermin D, Marti A, Lafon ME, Dutkiewicz AS, Léauté-Labrèze C, Boralevi F.

Arch Dis Child. 2017 Sep;102(9):868-869. doi: 10.1136/archdischild-2016-312107. Epub 2017 Jan 12. No abstract available.

PMID:
28082320
12.

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, Gautier S, Ortis V, Lafon M, Montagne A, Delarue A, Voisard JJ.

Pediatrics. 2016 Oct;138(4). pii: e20160353. Review.

13.

Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.

Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel MP, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M.

J Virol. 2016 Oct 14;90(21):9683-9692. doi: 10.1128/JVI.01347-16. Print 2016 Nov 1.

14.

Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38γ.

Maisonneuve P, Caillet-Saguy C, Vaney MC, Bibi-Zainab E, Sawyer K, Raynal B, Haouz A, Delepierre M, Lafon M, Cordier F, Wolff N.

J Biol Chem. 2016 Aug 5;291(32):16699-708. doi: 10.1074/jbc.M115.707208. Epub 2016 May 31.

15.

Strategies to interfere with PDZ-mediated interactions in neurons: What we can learn from the rabies virus.

Caillet-Saguy C, Maisonneuve P, Delhommel F, Terrien E, Babault N, Lafon M, Cordier F, Wolff N.

Prog Biophys Mol Biol. 2015 Oct;119(1):53-9. doi: 10.1016/j.pbiomolbio.2015.02.007. Epub 2015 Mar 5. Review.

PMID:
25748547
16.

Gigabar spherical shock generation on the OMEGA laser.

Nora R, Theobald W, Betti R, Marshall FJ, Michel DT, Seka W, Yaakobi B, Lafon M, Stoeckl C, Delettrez J, Solodov AA, Casner A, Reverdin C, Ribeyre X, Vallet A, Peebles J, Beg FN, Wei MS.

Phys Rev Lett. 2015 Jan 30;114(4):045001. Epub 2015 Jan 27.

PMID:
25679896
17.

Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France.

Vareil MO, Rouibi G, Kassab S, Soula V, Duffau P, Lafon ME, Neau D, Cazanave C.

Med Mal Infect. 2014 Dec;44(11-12):502-8. doi: 10.1016/j.medmal.2014.09.006. Epub 2014 Oct 25.

PMID:
25391635
18.

PDZ domain-mediated protein interactions: therapeutic targets in neurological disorders.

Khan Z, Lafon M.

Curr Med Chem. 2014;21(23):2632-41. Review.

PMID:
24606518
19.

Protective role of LGP2 in influenza virus pathogenesis.

Si-Tahar M, Blanc F, Furio L, Chopy D, Balloy V, Lafon M, Chignard M, Fiette L, Langa F, Charneau P, Pothlichet J.

J Infect Dis. 2014 Jul 15;210(2):214-23. doi: 10.1093/infdis/jiu076. Epub 2014 Feb 3.

PMID:
24493823
20.

Asymmetrical loading during non-visual navigation.

Kolev OI, Lafon M, Zanelli G, Berthoz A.

Neurosci Lett. 2013 Dec 17;557 Pt B:138-42.

PMID:
24466596
21.

Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.

Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon ME, Lina B, Del Giudice P; Clinical Research Group of the French Society of Pediatric Dermatology Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique.

Pediatr Infect Dis J. 2014 Apr;33(4):e92-8. doi: 10.1097/INF.0000000000000120.

PMID:
24463804
22.

Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.

Kassab S, Saghi T, Boyer A, Lafon ME, Gruson D, Lina B, Fleury H, Schuffenecker I.

Emerg Infect Dis. 2013 Aug;19(8):1345-7. doi: 10.3201/eid1908.130202. No abstract available.

23.

Ordered phosphorylation events in two independent cascades of the PTEN C-tail revealed by NMR.

Cordier F, Chaffotte A, Terrien E, Préhaud C, Theillet FX, Delepierre M, Lafon M, Buc H, Wolff N.

J Am Chem Soc. 2012 Dec 19;134(50):20533-43. doi: 10.1021/ja310214g. Epub 2012 Dec 7.

PMID:
23171049
24.

Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction.

Couzi L, Helou S, Bachelet T, Martin S, Moreau K, Morel D, Lafon ME, Garrigue I, Merville P.

Transplant Proc. 2012 Nov;44(9):2809-13. doi: 10.1016/j.transproceed.2012.09.029.

PMID:
23146529
25.

Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN.

Terrien E, Chaffotte A, Lafage M, Khan Z, Préhaud C, Cordier F, Simenel C, Delepierre M, Buc H, Lafon M, Wolff N.

Sci Signal. 2012 Aug 14;5(237):ra58. doi: 10.1126/scisignal.2002941.

26.

Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological features.

Berciaud S, Rayne F, Kassab S, Jubert C, Faure-Della Corte M, Salin F, Wodrich H, Lafon ME; Typadeno Study Members.

J Clin Virol. 2012 Aug;54(4):302-7. doi: 10.1016/j.jcv.2012.04.009. Epub 2012 May 17.

PMID:
22608365
27.

Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death.

Babault N, Cordier F, Lafage M, Cockburn J, Haouz A, Prehaud C, Rey FA, Delepierre M, Buc H, Lafon M, Wolff N.

Structure. 2011 Oct 12;19(10):1518-24. doi: 10.1016/j.str.2011.07.007.

28.

High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy.

Couzi L, Helou S, Bachelet T, Moreau K, Martin S, Morel D, Lafon ME, Boyer B, Alain S, Garrigue I, Merville P.

Am J Transplant. 2012 Jan;12(1):202-9. doi: 10.1111/j.1600-6143.2011.03766.x. Epub 2011 Oct 3.

29.

The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Chopy D, Detje CN, Lafage M, Kalinke U, Lafon M.

J Neurovirol. 2011 Aug;17(4):353-67. doi: 10.1007/s13365-011-0041-6. Epub 2011 Jul 30.

PMID:
21805057
30.

Evasive strategies in rabies virus infection.

Lafon M.

Adv Virus Res. 2011;79:33-53. doi: 10.1016/B978-0-12-387040-7.00003-2. Review.

PMID:
21601041
31.

Ambivalent role of the innate immune response in rabies virus pathogenesis.

Chopy D, Pothlichet J, Lafage M, Mégret F, Fiette L, Si-Tahar M, Lafon M.

J Virol. 2011 Jul;85(13):6657-68. doi: 10.1128/JVI.00302-11. Epub 2011 Apr 27.

32.

CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.

Bruyand M, Vandenhende MA, Marcel G, Lazaro E, Lafon ME, Dupon M, Dabis F, Geffard S, Fleury H, Faure-Della Corte M, Bonnet F, Thiebaut R, Garrigue I.

J Clin Virol. 2011 Feb;50(2):177-80. doi: 10.1016/j.jcv.2010.10.021. Epub 2010 Dec 3.

PMID:
21126905
33.

Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature.

Brun JL, Randriambelomanana J, Cherier L, Lafon ME, Trufflandier N, Le Bail B.

Int J Gynecol Pathol. 2010 Sep;29(5):427-31. doi: 10.1097/PGP.0b013e3181db69da. Review.

PMID:
20736767
34.

[Persistent influenza virus infection in a patient treated with alemtuzumab].

Burrel S, Dilhuydy S, Bouabdallah K, Lafon MÉ, Milpied N, Fleury H.

Med Mal Infect. 2010 Nov;40(11):657-9. doi: 10.1016/j.medmal.2010.03.001. Epub 2010 Jul 16. French. No abstract available.

PMID:
20638206
35.

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.

Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D.

Curr HIV Res. 2010 Sep;8(6):461-6.

PMID:
20636276
36.

The transcriptional activity of Neurog3 affects migration and differentiation of ectopic endocrine cells in chicken endoderm.

Rosenberg LC, Lafon ML, Pedersen JK, Yassin H, Jensen JN, Serup P, Hecksher-Sørensen J.

Dev Dyn. 2010 Jul;239(7):1950-66. doi: 10.1002/dvdy.22329.

37.

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

Préhaud C, Wolff N, Terrien E, Lafage M, Mégret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Ménager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M.

Sci Signal. 2010 Jan 19;3(105):ra5. doi: 10.1126/scisignal.2000510.

38.

Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients.

Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Déchanet-Merville J, Fleury HJ, Lafon ME.

J Clin Virol. 2010 Feb;47(2):161-9. doi: 10.1016/j.jcv.2009.11.023.

PMID:
20022297
39.

Latent viral infections of the nervous system: role of the host immune response.

Lafon M.

Rev Neurol (Paris). 2009 Dec;165(12):1039-44. doi: 10.1016/j.neurol.2009.09.010. Review.

40.
41.

Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.

Couzi L, Pitard V, Netzer S, Garrigue I, Lafon ME, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.

J Infect Dis. 2009 Nov 1;200(9):1415-24. doi: 10.1086/644509.

PMID:
19780672
42.

Cluster of chikungunya virus infection in travelers returning from Senegal, 2006.

Pistone T, Ezzedine K, Boisvert M, Receveur MC, Schuffenecker I, Zeller H, Lafon ME, Fleury H, Malvy D.

J Travel Med. 2009 Jul-Aug;16(4):286-8. doi: 10.1111/j.1708-8305.2008.00294.x.

43.

1H, 13C and 15N resonance assignments of the PDZ of microtubule-associated serine/threonine kinase 205 (MAST205) in complex with the C-terminal motif from the rabies virus glycoprotein.

Terrien E, Simenel C, Prehaud C, Buc H, Delepierre M, Lafon M, Wolff N.

Biomol NMR Assign. 2009 Jun;3(1):45-8. doi: 10.1007/s12104-008-9138-0. Epub 2009 Jan 13.

PMID:
19636944
44.

Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study.

Amiel C, Legoff J, Lescure FX, Coste-Burel M, Deback C, Fafi-Kremer S, Gueudin M, Lafon ME, Leruez-Ville M, Mengelle C, Payan C, Pillet S.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):427-9. doi: 10.1097/QAI.0b013e31819a22ec. No abstract available.

PMID:
19322036
45.

Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies.

Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Préhaud C, Lafon M.

PLoS Pathog. 2009 Feb;5(2):e1000315. doi: 10.1371/journal.ppat.1000315. Epub 2009 Feb 27.

46.

Selective influence of prior allocentric knowledge on the kinesthetic learning of a path.

Lafon M, Vidal M, Berthoz A.

Exp Brain Res. 2009 Apr;194(4):541-52. doi: 10.1007/s00221-009-1728-2. Epub 2009 Feb 20.

PMID:
19229527
47.

UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.

Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L, Lebrette ME, Schrive MH, Roncin L, Taupin JL, Déchanet-Merville J, Fleury H, Lafon ME.

Transplantation. 2008 Sep 27;86(6):826-35. doi: 10.1097/TP.0b013e3181859edd.

PMID:
18813108
48.

Immune evasion, a critical strategy for rabies virus.

Lafon M.

Dev Biol (Basel). 2008;131:413-9. Review.

PMID:
18634503
49.

Occult hepatitis B in HIV-HCV coinfected patients.

Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

Scand J Infect Dis. 2008;40(10):835-9. doi: 10.1080/00365540801918511.

PMID:
18609222
50.

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection.

Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2008 Aug 15;112(4):1317-24. doi: 10.1182/blood-2008-01-136713. Epub 2008 Jun 6.

Supplemental Content

Support Center